The purpose of this study is to evaluate the efficacy and safety of DDGP regiment
(gemcitabine，pegaspargase,cisplatin,dexamethasone) for patients with stage Ⅲ/Ⅳ Natural Killer
(NK)/T Cell Lymphoma.
Phase:
Phase 4
Details
Lead Sponsor:
Mingzhi Zhang
Collaborators:
Cancer Hospital of Guizhou Province Qingdao University Second Hospital of Shanxi Medical University Shanxi Province Cancer Hospital The First Affiliated Hospital of Henan University of Traditional Chinese Medicine Wuhan TongJi Hospital Wuhan Union Hospital, China Wuhan University Xinyang Central Hospital